These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 23234514)

  • 41. One-unit versus two-unit cord-blood transplantation for hematologic cancers.
    Wagner JE; Eapen M; Carter S; Wang Y; Schultz KR; Wall DA; Bunin N; Delaney C; Haut P; Margolis D; Peres E; Verneris MR; Walters M; Horowitz MM; Kurtzberg J;
    N Engl J Med; 2014 Oct; 371(18):1685-94. PubMed ID: 25354103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
    Avery S; Voss MH; Gonzales AM; Lubin M; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Hedvat CV; Stevens CE; Barker JN
    Bone Marrow Transplant; 2012 Aug; 47(8):1056-60. PubMed ID: 22139066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-Thaw Viable CD45+ Cells and Clonogenic Efficiency are Associated with Better Engraftment and Outcomes after Single Cord Blood Transplantation in Adult Patients with Malignant Diseases.
    Castillo N; García-Cadenas I; Barba P; Martino R; Azqueta C; Ferrà C; Canals C; Sierra J; Valcárcel D; Querol S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2167-2172. PubMed ID: 26319094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.
    Nishida T; Kobayashi T; Sawa M; Masuda S; Shibasaki Y; Goto T; Fukuhara N; Fujii N; Ikegame K; Sugita J; Ikeda T; Kuwatsuka Y; Suzuki R; Najima Y; Doki N; Kato T; Inagaki Y; Utsu Y; Aotsuka N; Masuko M; Terakura S; Onishi Y; Maeda Y; Okada M; Teshima T; Murata M
    Ann Hematol; 2021 Mar; 100(3):743-752. PubMed ID: 33427909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ex vivo expansion of umbilical cord blood for transplantation.
    Tung SS; Parmar S; Robinson SN; De Lima M; Shpall EJ
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):245-57. PubMed ID: 20837337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases.
    Ding J; Fang Y; Zhou R; Gu Y; Du S; Lu Q; Yue Q
    Cell Transplant; 2022; 31():9636897211070238. PubMed ID: 35073786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
    Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes.
    Bradstock K; Hertzberg M; Kerridge I; Svennilson J; George B; McGurgan M; Huang G; Antonenas V; Gottlieb D
    Intern Med J; 2009 Nov; 39(11):744-51. PubMed ID: 19220530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adults requiring cord blood transplants but have insufficient cell doses from a single cord blood unit can receive two units with successful engraftment kinetics similar to those of children receiving a single unit.
    Goldstein G; Elhasid R; Bielorai B; Shimoni A; Yerushalmi R; Kassis I; Nagler A
    Leuk Lymphoma; 2011 Apr; 52(4):635-41. PubMed ID: 21338286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.
    Wagner JE; Brunstein CG; Boitano AE; DeFor TE; McKenna D; Sumstad D; Blazar BR; Tolar J; Le C; Jones J; Cooke MP; Bleul CC
    Cell Stem Cell; 2016 Jan; 18(1):144-55. PubMed ID: 26669897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
    Hsu J; Artz A; Mayer SA; Guarner D; Bishop MR; Reich-Slotky R; Smith SM; Greenberg J; Kline J; Ferrante R; Phillips AA; Gergis U; Liu H; Stock W; Cushing M; Shore TB; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):359-365. PubMed ID: 29128555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].
    Liao C; Yang X; Xu ZP; Huang YN; Wu SQ; Chen JS; Li Y; Tang XW; Wu JY
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):220-3. PubMed ID: 16624064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.
    Brunstein CG; Barker JN; Weisdorf DJ; Defor TE; McKenna D; Chong SY; Miller JS; McGlave PB; Wagner JE
    Bone Marrow Transplant; 2009 Jun; 43(12):935-40. PubMed ID: 19139736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
    Eldjerou LK; Chaudhury S; Baisre-de Leon A; He M; Arcila ME; Heller G; O'Reilly RJ; Barker JN; Moore MA
    Blood; 2010 Nov; 116(19):3999-4006. PubMed ID: 20587781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
    Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.
    Purtill D; Smith K; Devlin S; Meagher R; Tonon J; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Stevens CE; Barker JN
    Blood; 2014 Nov; 124(19):2905-12. PubMed ID: 25185264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.